Literature DB >> 15557187

Nitric oxide inhibits IgE-dependent cytokine production and Fos and Jun activation in mast cells.

Beverley J Davis1, Brian F Flanagan, Alasdair M Gilfillan, Dean D Metcalfe, John W Coleman.   

Abstract

NO is a cell-derived radical reported to inhibit mast cell degranulation and subsequent allergic inflammation, although whether its action is nonspecific or occurs via specific molecular mechanisms remains unknown. To examine this question, we set out to determine whether NO inhibits mast cell cytokine production, and, if so, whether it also alters FcepsilonRI-dependent signal transduction. As hypothesized, the radical inhibited IgE/Ag-induced IL-4, IL-6, and TNF production. Although NO did not influence phosphorylated JNK, p38 MAPK, or p44/42 MAPK, it did inhibit phosphorylation of phospholipase Cgamma1 and the AP-1 transcription factor protein c-Jun, but not NF-kappaB or CREB. NO further completely abrogated IgE/Ag-induced DNA-binding activity of the nuclear AP-1 proteins Fos and Jun. These results show that NO is capable of inhibiting FcepsilonRI-dependent mast cell cytokine production at the level of gene regulation, and suggest too that NO may contribute to resolution of allergic inflammation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15557187     DOI: 10.4049/jimmunol.173.11.6914

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

Review 1.  Mast cells and inflammation.

Authors:  Theoharis C Theoharides; Konstantinos-Dionysios Alysandratos; Asimenia Angelidou; Danae-Anastasia Delivanis; Nikolaos Sismanopoulos; Bodi Zhang; Shahrzad Asadi; Magdalini Vasiadi; Zuyi Weng; Alexandra Miniati; Dimitrios Kalogeromitros
Journal:  Biochim Biophys Acta       Date:  2010-12-23

2.  Human airway epithelial cell determinants of survival and functional phenotype for primary human mast cells.

Authors:  F H Hsieh; P Sharma; A Gibbons; T Goggans; S C Erzurum; S J Haque
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-26       Impact factor: 11.205

3.  Genetic polymorphisms in arginase I and II and childhood asthma and atopy.

Authors:  Huiling Li; Isabelle Romieu; Juan-Jose Sienra-Monge; Matiana Ramirez-Aguilar; Blanca Estela Del Rio-Navarro; Emily O Kistner; Håkon K Gjessing; Irma Del Carmen Lara-Sanchez; Grace Y Chiu; Stephanie J London
Journal:  J Allergy Clin Immunol       Date:  2005-11-28       Impact factor: 10.793

4.  Estrogen attenuates chronic volume overload induced structural and functional remodeling in male rat hearts.

Authors:  Jason D Gardner; David B Murray; Tetyana G Voloshenyuk; Gregory L Brower; Jessica M Bradley; Joseph S Janicki
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-11-20       Impact factor: 4.733

5.  Mast cell activation contributes to sickle cell pathobiology and pain in mice.

Authors:  Lucile Vincent; Derek Vang; Julia Nguyen; Mihir Gupta; Kathryn Luk; Marna E Ericson; Donald A Simone; Kalpna Gupta
Journal:  Blood       Date:  2013-06-17       Impact factor: 22.113

Review 6.  Inflammatory targets of therapy in sickle cell disease.

Authors:  Amma Owusu-Ansah; Chibueze A Ihunnah; Aisha L Walker; Solomon F Ofori-Acquah
Journal:  Transl Res       Date:  2015-07-11       Impact factor: 7.012

7.  Severe vitamin E deficiency modulates airway allergic inflammatory responses in the murine asthma model.

Authors:  Yunsook Lim; Vihas T Vasu; Giuseppe Valacchi; Scott Leonard; Hnin Hnin Aung; Bettina C Schock; Nicholas J Kenyon; Chin-Shang Li; Maret G Traber; Carroll E Cross
Journal:  Free Radic Res       Date:  2008-04

8.  Interferon-gamma regulates chemokine expression and release in the human mast cell line HMC1: role of nitric oxide.

Authors:  M Gilchrist; A D Befus
Journal:  Immunology       Date:  2007-07-28       Impact factor: 7.397

9.  Nanofiber-coated drug eluting stent for the stabilization of mast cells.

Authors:  Byeongtaek Oh; Chi H Lee
Journal:  Pharm Res       Date:  2014-03-25       Impact factor: 4.200

10.  Synthesis and structure-activity relationships of novel 5-(hydroxamic acid)methyl oxazolidinone derivatives as 5-lipoxygenase inhibitors.

Authors:  Oludotun A Phillips; Mira A Bosso; Charles I Ezeamuzie
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.